- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Bivalent mRNA vaccine effectiveness against SARS-CoV-2 variants of concern ; volume:30 ; number:1 ; day:28 ; month:6 ; year:2023 ; pages:1-11 ; date:12.2023
Journal of biomedical science ; 30, Heft 1 (28.6.2023), 1-11, 12.2023
- Creator
-
Kumari, Monika
Su, Shih-Chieh
Liang, Kang-Hao
Lin, Hsiu-Ting
Lu, Yu-Feng
Chen, Kai-Chi
Chen, Wan-Yu
Wu, Han-Chung
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12929-023-00936-0
- URN
-
urn:nbn:de:101:1-2023092909464501295691
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kumari, Monika
- Su, Shih-Chieh
- Liang, Kang-Hao
- Lin, Hsiu-Ting
- Lu, Yu-Feng
- Chen, Kai-Chi
- Chen, Wan-Yu
- Wu, Han-Chung
- SpringerLink (Online service)
Other Objects (12)
Differential long-term bivalent HPV vaccine cross-protection by variants in the Costa Rica HPV vaccine trial
Hetero-bivalent nanobodies provide broad-spectrum protection against SARS-CoV-2 variants of concern including Omicron
Bivalent norovirus mRNA vaccine elicits cellular and humoral responses protecting human enteroids from GII.4 infection
Bivalent mRNA vaccine booster induces robust antibody immunity against Omicron lineages BA.2, BA.2.12.1, BA.2.75 and BA.5
A potent, broadly protective vaccine against SARS-CoV-2 variants of concern
Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants
Human leukocyte antigen variants associate with BNT162b2 mRNA vaccine response
mRNA-1273 bivalent (original and Omicron) COVID-19 vaccine effectiveness against COVID-19 outcomes in the United States
Elicitation of protective immune responses using a bivalent H5N1 VLP vaccine
Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine
Bivalent mRNA vaccine effectiveness against COVID-19 among older adults in Japan: a test-negative study from the VENUS study
Human Papillomavirus Genotype Distribution Patterns in Zimbabwe: Is the Bivalent Vaccine Sufficient?
Differential long-term bivalent HPV vaccine cross-protection by variants in the Costa Rica HPV vaccine trial
Hetero-bivalent nanobodies provide broad-spectrum protection against SARS-CoV-2 variants of concern including Omicron
Bivalent norovirus mRNA vaccine elicits cellular and humoral responses protecting human enteroids from GII.4 infection
Bivalent mRNA vaccine booster induces robust antibody immunity against Omicron lineages BA.2, BA.2.12.1, BA.2.75 and BA.5
A potent, broadly protective vaccine against SARS-CoV-2 variants of concern
Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants
Human leukocyte antigen variants associate with BNT162b2 mRNA vaccine response
mRNA-1273 bivalent (original and Omicron) COVID-19 vaccine effectiveness against COVID-19 outcomes in the United States
Elicitation of protective immune responses using a bivalent H5N1 VLP vaccine
Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine
Bivalent mRNA vaccine effectiveness against COVID-19 among older adults in Japan: a test-negative study from the VENUS study
Human Papillomavirus Genotype Distribution Patterns in Zimbabwe: Is the Bivalent Vaccine Sufficient?
Differential long-term bivalent HPV vaccine cross-protection by variants in the Costa Rica HPV vaccine trial
Hetero-bivalent nanobodies provide broad-spectrum protection against SARS-CoV-2 variants of concern including Omicron
Bivalent norovirus mRNA vaccine elicits cellular and humoral responses protecting human enteroids from GII.4 infection
Bivalent mRNA vaccine booster induces robust antibody immunity against Omicron lineages BA.2, BA.2.12.1, BA.2.75 and BA.5
A potent, broadly protective vaccine against SARS-CoV-2 variants of concern
Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants
Human leukocyte antigen variants associate with BNT162b2 mRNA vaccine response
mRNA-1273 bivalent (original and Omicron) COVID-19 vaccine effectiveness against COVID-19 outcomes in the United States
Elicitation of protective immune responses using a bivalent H5N1 VLP vaccine
Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine
Bivalent mRNA vaccine effectiveness against COVID-19 among older adults in Japan: a test-negative study from the VENUS study